Predicting survival of cancer patients by chromosomal copy number heterogeneity

We recently introduced a method to derive intra-tumor heterogeneity (ITH) from a single copy number measurement. This method stratifies patients for survival and could potentially help to identify low and high-risk patients with clinical relevance.

Detalles Bibliográficos
Autores principales: Van Den Bosch, Tom, van Dijk, Erik, Vermeulen, Louis, Miedema, Daniël M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Author’s Views
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489936/
https://www.ncbi.nlm.nih.gov/pubmed/34616875
http://dx.doi.org/10.1080/23723556.2021.1949956
Descripción
Sumario:We recently introduced a method to derive intra-tumor heterogeneity (ITH) from a single copy number measurement. This method stratifies patients for survival and could potentially help to identify low and high-risk patients with clinical relevance.

Ejemplares similares